Quality of life with pharmacological treatment in patients with benign prostatic enlargement: results from the Evolution European Prospective Multicenter Multi-National Registry Study.
Nikita R BhattNiall F DavisW P WitjesA BjartellC CarisA PatelA de la TailleA TubaroPublished in: World journal of urology (2020)
After 5-years from the onset of symptoms, LUTS/BPE patients previously treated with medication had significantly impaired QOL in patients in a manner comparable to other chronic diseases. Earlier intervention with minimally invasive surgical techniques (MIT) should be considered in LUTS/BPE patients that do not show a significant improvement in QOL with medical therapy.
Keyphrases
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- minimally invasive
- randomized controlled trial
- healthcare
- prostate cancer
- emergency department
- stem cells
- physical activity
- benign prostatic hyperplasia
- cross sectional
- combination therapy
- smoking cessation
- lower urinary tract symptoms
- radical prostatectomy
- replacement therapy
- drug induced